Physician profile
Daniel Urias
NPI 1366881773
$3,470.45
in general payments reported to CMS, 2019-2025
18 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $46.18 · 2021: $504 · 2022: $285 · 2024: $1,139 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,002 · Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,001.53 |
| Food and Beverage | $405.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,001.53 | 2024 | Acell, Durasorb Monofilament Mesh |
| Allergan, INC. | $871.64 | 2019 | |
| Medical Device Business Services, INC. | $284.71 | 2022 | |
| Mentor Worldwide LLC | $231.78 | 2019-2021 | |
| Revance Therapeutics, INC. | $179.40 | 2025 | Daxi, Daxxify |
| Musculoskeletal Transplant Foundation INC. | $142.59 | 2021 | |
| Ethicon US, LLC | $129.30 | 2019 | |
| Abbvie INC. | $119.22 | 2024-2025 | |
| Acumed LLC | $113.60 | 2021 | |
| Polynovo North America LLC | $85.40 | 2019 | |
| Sientra, INC. | $76.70 | 2021 | |
| Kerecis Limited | $61.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $46.18 | 2020 | |
| Bard Peripheral Vascular, INC. | $33.01 | 2021 | |
| Baxter Healthcare | $26.64 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $25.91 | 2019 | |
| Tela Bio, INC. | $23.00 | 2021 | |
| Merz North America, INC. | $18.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Urias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.